Lilly's Foundayo and lower-dose Zepbound helped people maintain weight loss afte...
Lilly's Foundayo and lower-dose Zepbound helped people maintain weight loss after switching from higher doses of injectable incretin therapy in two late-phase trials
Full article content is being loaded. Please check back shortly.
Author: investor.lilly.com
Read Original Article